FDA Approves Roche’s Tecentriq and Lurbinectedin Combo as First Maintenance Therapy for Advanced Small Cell Lung Cancer Read more
FDA Grants Fast Track Designation to Bristol Myers Squibb’s Alzheimer’s Antibody BMS-986446 Read more
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients Read more